Compound details
Capsiate
| Compound ID | CDAMM02262 |
|---|---|
| Common name | Capsiate | IUPAC name | (4-hydroxy-3-methoxyphenyl)methyl 8-methylnon-6-enoate |
| Molecular formula | C18H26O4 |
| Retention time | 12.71 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 307.191 | Theoretical mz | 307.19 |
| Error | 1.71 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.056 |
| Inchi key | ZICNYIDDNJYKCP-SOFGYWHQSA-N |
|---|---|
| Smiles | O=C(OCC1=CC=C(O)C(OC)=C1)CCCCC=CC(C)C |
| Superclass | Benzenoids |
| Class | Phenols |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SwissTargetPrediction |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SwissTargetPrediction and SEA |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| Q7Z2W7 | TRPM8 | Transient receptor potential cation channel subfamily M member 8 | T41955 | SEA |
| Q13547 | HDAC1 | Histone deacetylase 1 | T68547 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SEA |
| P18054 | ALOX12 | Arachidonate 12-lipoxygenase | T35527 | SwissTargetPrediction |
| Q09472 | EP300 | Histone acetyltransferase p300 | T25956 | SEA |
| P47871 | GCGR | Glucagon receptor | T60182 | SwissTargetPrediction and SEA |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SEA |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P25098 | GRK2 | G-protein coupled receptor kinase 2 | T62548 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| Q13093 | PLA2G7 | LDL-associated phospholipase A2 | T69912 | SwissTargetPrediction |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | T54582 | SwissTargetPrediction |
| P16234 | PDGFRA | Platelet-derived growth factor receptor | T53524 | SwissTargetPrediction |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SwissTargetPrediction |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SwissTargetPrediction and SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| Q9HBW0 | LPAR2 | Lysophosphatidic acid receptor Edg-4 | T39380 | SEA |
| P37840 | SNCA | Alpha-synuclein | T03644 | SwissTargetPrediction |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| P43657 | LPAR6 | Lysophosphatidic acid receptor 6 | T13484 | SEA |
| Q9UBY5 | LPAR3 | Lysophosphatidic acid receptor Edg-7 | T95923 | SEA |
| Q92633 | LPAR1 | Lysophosphatidic acid receptor Edg-2 | T92640 | SEA |
| Q99677 | LPAR4 | Lysophosphatidic acid receptor 4 | T58130 | SEA |
| P00488 | F13A1 | Coagulation factor XIII | T66925 | SwissTargetPrediction |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SEA |
| P24593 | IGFBP5 | Insulin-like growth factor binding protein 5 | T17008 | SEA |
| P41586 | ADCYAP1R1 | Pituitary adenylate cyclase-activating polypeptide type I receptor | T92185 | SEA |
| Q9NYN9 | PTPN13 | FAP-1 messenger RNA | T09672 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| Q9NR20 | DYRK4 | Dual-specificity tyrosine-phosphorylation regulated kinase 4 | T20542 | SEA |
| Q8N183 | NDUFAF2 | HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2 | T01453 | SEA |
| Q9P0J0 | NDUFA13 | Mitochondrial complex I | T82391 | SEA |
| Q9Y6M9 | NDUFB9 | HUMAN NADH:ubiquinone oxidoreductase subunit B9 | T01465 | SEA |
| Q8N183 | NDUFAF2 | HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2 | T01453 | SEA |
| P03897 | MT-ND3 | NADH dehydrogenase | T77195 | SEA |
| O75751 | EMTH | Organic cation transporter 3 | T55948 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T41955 | DI0422 | Upper respiratory tract disorder | [ICD-11: CA0Z] | Q7Z2W7 | TRPM8 |
| T68547 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q13547 | HDAC1 |
| T68547 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q13547 | HDAC1 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T25956 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q09472 | EP300 |
| T25956 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q09472 | EP300 |
| T60182 | DI0193 | Hypo-glycaemia | [ICD-11: 5A41] | P47871 | GCGR |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T69912 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q13093 | PLA2G7 |
| T69912 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q13093 | PLA2G7 |
| T69912 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | Q13093 | PLA2G7 |
| T54582 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P43490 | NAMPT |
| T54582 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P43490 | NAMPT |
| T54582 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43490 | NAMPT |
| T53524 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P16234 | PDGFRA |
| T53524 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P16234 | PDGFRA |
| T53524 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P16234 | PDGFRA |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T03644 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37840 | SNCA |
| T03644 | DI0044 | Autonomic nervous system disorder | [ICD-11: 8D87] | P37840 | SNCA |
| T03644 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P37840 | SNCA |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T95923 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9UBY5 | LPAR3 |
| T95923 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q9UBY5 | LPAR3 |
| T92640 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q92633 | LPAR1 |
| T92640 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q92633 | LPAR1 |
| T92640 | DI0351 | Psoriasis | [ICD-11: EA90] | Q92633 | LPAR1 |
| T92640 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q92633 | LPAR1 |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |
| T92185 | DI0264 | Migraine | [ICD-11: 8A80] | P41586 | ADCYAP1R1 |
| T82391 | DI0069 | Cardiomyopathy | [ICD-11: BC43] | Q9P0J0 | NDUFA13 |
| T77195 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P03897 | MT-ND3 |